-3%

est. 2Y upside i

CybersecuritySeries D+

Rank

#3500

Sector

Cybersecurity

Est. Liquidity

~2Y

Data Quality

Data: Medium

Delinea presents a moderate upside opportunity, driven by its strong market leadership in Privileged Access Management (PAM) with ARR approaching $400M and consistent profitability.

Last updated: March 10, 2026

Bull (30%)+100%

Delinea successfully executes its IPO, leveraging its leadership in PAM and recent AI-driven innovations like Iris AI and the StrongDM acquisition to capture significant market share, especially in securing non-human identities. This drives ARR to over $600M by 2028, justifying a premium 16x revenue multiple and a $6.4B valuation at IPO.

Base (30%)0%

Delinea maintains its strong position as a PAM leader, growing steadily but facing continued pressure from major incumbents like CyberArk and Microsoft Entra ID. ARR reaches approximately $500M by 2028, leading to an IPO or acquisition at a valuation of around $3.2B, consistent with the current estimated 8x ARR multiple.

Bear (40%)-40%

Intensified competition from broad IAM platforms and specialized PAM vendors, coupled with slower-than-expected adoption of new AI-driven security features, limits Delinea's growth. ARR growth decelerates, and the company struggles to differentiate, resulting in a valuation compression to a 4.8x revenue multiple, leading to a $1.92B valuation and significant impairment of common stock value due to TPG's liquidation preferences.

Est. time to liquidity~1.5 years

Preference Stack Risk

severe

TPG Capital's estimated equity investment of at least $1.4 billion (from the Thycotic acquisition alone) represents a significant liquidation preference ahead of common stock, which is approximately 44% of the estimated current valuation of $3.2 billion.

Dilution Risk

moderate

While recent acquisitions like StrongDM can drive growth, they may involve further equity issuance or debt, potentially diluting existing common shareholders if not highly accretive.

Secondary Liquidity

none

As a private equity-backed company, there is currently no active secondary market for Delinea's common stock, and liquidity is tied to a future exit event like an IPO or acquisition.

Other — 1 role

View all 1 open roles at Centrify →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Centrify's data — designed to show you've done your homework.

  • 1

    “Given Delinea's strong position in PAM and recent acquisitions like StrongDM, how is the company strategically positioning itself against broader identity and access management platforms from incumbents like Microsoft Entra ID and Okta?”

  • 2

    “With ARR approaching $400M and a reported IPO consideration, what are the key milestones and growth levers Delinea is focused on to achieve a successful public offering in the next 1-2 years?”

  • 3

    “As an employee considering equity, how does Delinea's current capital structure, particularly TPG's investment, impact the potential returns for common stock holders in various exit scenarios?”

Community

Valuation Sentiment

Our model estimates -3% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.